Storys zum Thema Finanzen
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- 2mehr
Allianz puts The Squared Ball in play and launches campaign for financial coaching in women's football
mehrdpa Deutsche Presse-Agentur GmbH
2Financial results 2022: dpa group remains on a growth path
mehrHeidelberger Druckmaschinen AG
HEIDELBERG sets a new course following a successful financial year
Heidelberg (ots) - - Targets met in a difficult economic environment in financial year 2022/2023– free cash flow benefits from non-recurring effects - New strategy offers prospects for the future – expanding scope of printing and unlocking new markets - Growth through own internal efforts – HEIDELBERG initiates value creation program to strengthen financial power ...
mehrCroma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China
Vienna (ots/PRNewswire) - Croma-Pharma® ('Croma') announced today that in June the first patient will be enrolled in the clinical trial1 for the approval of its hyaluronic acid dermal filler Princess® Volume Plus Lidocaine2 in China. The randomised, multi-centre, evaluator blinded, parallel group, active ...
mehrPwC Strategy& study: IBAN-name checks can increase confidence in instant payments, but are not a universal solution
Munich (ots) - ● Instant payments are becoming more popular in Europe, but at the same time attract fraudsters ● In future, according to draft EU legislation, banks should therefore check before every payment whether the IBAN and account-holder name match ● Banks and payment service providers take a nuanced ...
mehrOsmium-Institut zur Inverkehrbringung und Zertifizierung von Osmium GmbH
Osmium Fork Leads to Price Reduction and Free Compensation Deliveries
mehrCroma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe
Vienna (ots/PRNewswire) - Croma-Pharma, a global player and challenger in the dynamically growing, minimally invasive aesthetics market, announces that it will launch Pliaglis®, a topical local anaesthetic for superficial dermatological procedures, in its European core markets including Germany, the United Kingdom ("UK"), and Ireland. Further markets including Brazil will follow by the end of 2023. The anaesthetic cream ...
mehrScrive: Learn about the Nordic way of onboarding at Money 20/20
Munich (ots) - Scrive, Swedish provider of customer onboarding services, will be attending the Money 20/20 Conference in Amsterdam, June 6-8. Scrive invites interested parties to visit their booth (Hall 3, J33) and take part in the interactive sessions they will be co-hosting with their long-time partner BankID. Scrive has served as a trusted partner to organisations in banking, financial services and insurance who want ...
mehrLONGi Green Energy Technology Co., Ltd.
LONGi publishes its annual report for 2022 and 2023 Q1
Xi'an, China / Frankfurt, Germany (ots) - LONGi Green Energy Technology, a global leading renewable energy company, released its annual report for 2022 and 2023 Q1. According to the financial report, the company achieved a revenue of 128.998 billion yuan in 2022 (USD 19.27 bn), a year-on-year increase of 60.03%. This is the first time that LONGi’s yearly revenue stands above the 100 bn yuan (USD 14.93 bn) level. For the ...
mehrIn Gold We Trust Report 2023 "Showdown"
Schaan / Vienna (ots) - On May 24, 2023, this year's - now 17th - In Gold We Trust report was presented at an international press conference broadcast live on the Internet. The authors of the report are the two fund managers Ronald-Peter Stöferle and Mark J. Valek from the Liechtenstein-based asset manager Incrementum AG. The 400+ page In Gold We Trust report is renowned worldwide and has been dubbed the "gold standard ...
mehrGermany Books Massive Foreign Direct Investment Increase in 2022
Berlin (ots) - The United States and post-Brexit Britain drove an unprecedented level of FDI in Germany in the past year. Even without a huge investment by chipmaker Intel, the value of business expansion was up considerably. Despite the economic turmoil following Russia’s war on Ukraine, 2022 was a record year for international business expansion to Germany. That’s the conclusion of the annual FDI Report by Germany ...
mehrNTT DATA Business Solutions AG
NTT DATA Business Solutions AG publishes key figures for fiscal year 2022/2023
mehrCroma-Pharma receives marketing authorisation for Letybo® in a further 12 European markets
Vienna (ots/PRNewswire) - Croma (Croma-Pharma® GmbH) announced today that it has received marketing authorisation for Letybo®, the company's botulinum toxin product, in 12 additional European markets. These include Belgium, Cyprus, Czech Republic, Denmark, Finland, Greece, Hungary, Luxembourg, Malta, Norway, Slovakia and Sweden. Letybo® will be launched in these ...
mehr/C O R R E C T I O N -- Croma-Pharma/
Vienna (ots/PRNewswire) - In the news release, Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter, issued 09-May-2023 by Croma-Pharma over PR Newswire, we are advised by the company that the footnote [1] has been updated. The complete, corrected release follows: Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter - ...
mehrCroma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter
Vienna (ots/PRNewswire) - - Company reports strong financial results for 2022 with 27% revenue growth in 2022 and significantly increased margins - Growth driven by launch of Letybo® and its catalytic effect on the existing portfolio as well as strong market growth - Continued market share gains, strategic mid-term ...
mehrHow effective can the Metatime’s MetaChain Blockchain Platform be in Turkey’s CBDC movement?
mehrFraport Group’s Business Performance Improves Noticeably in the First Quarter of 2023
Frankfurt/Main, Germany (ots) - Operating result (EBITDA) more than doubles to €158.3 million – Full-year outlook confirmed – CEO Schulte: We’re heading in the right direction. Business boosted by passenger recovery in the first quarter Fraport successfully started the new 2023 business year, ...
Ein DokumentmehrNeuraxpharm agrees on the divestment of inhalation API specialist Inke to Keensight Capital
Barcelona, Spain, Düsseldorf, Germany and Paris (ots/PRNewswire) - Transaction enables Neuraxpharm to further focus on its core CNS therapeutic area and for Inke to accelerate its development as an independent entity Neuraxpharm Group ("Neuraxpharm"), the leading European specialty pharmaceutical company focused on ...
mehrSTIHL sets revenue record and focuses on dual technological leadership
mehrGoals for 2022 achieved: DEKRA increases revenue and transforms for the future
mehrXella achieved solid results in 2022 and is well positioned to address the unabated need for affordable and sustainable building solutions
Duisburg (ots) - - Revenue increased to €1.37 billion in 2022 - Growth of 17 per cent compared to the previous year [1] - Product range increasingly meets demand for efficient and sustainable building solutions Xella Group, a leading European materials provider of sustainable, efficient, and affordable walling ...
mehrGerresheimer with a good start to 2023 financial year: Again double-digit growth in revenues and Adjusted EBITDA
Düsseldorf (ots) - - First-quarter revenues grew organically by 21.0% - Adjusted EBITDA up organically by 24.8% - Gerresheimer confirms guidance for financial year 2023 Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug ...
Ein DokumentmehrFinancial year 2022: GEMA stronger than ever with a record financial result
Munich (ots) - Despite the challenging situation in society and the economy as a whole, the German music collecting society and one of the world's largest authors' societies for musical works, GEMA, achieved its best result ever in 2022. Its total revenues for the financial year were EUR 1.178 billion (a more than 13 per cent increase on 2021's EUR 1.039 billion). For ...
mehrMakerVerse Secures 9.4 Million Euro Series A Funding to Expand On-Demand Manufacturing
Berlin (ots) - The funding will grow the company's AI-powered platform, helping companies build resilient supply chains. With manufacturers seeking an easier way to source industrial-quality parts, MakerVerse raised EUR9.4 million in series A funding to meet that need. MakerVerse will scale its AI-powered on-demand manufacturing platform for even faster growth. 9.5 ...
mehrSuccessful transaction: Adragos Pharma has officially taken over Clinigen’s development unit, Lamda Laboratories near Athens, Greece
Munich / London / Athens (ots) - - Adragos on a growth path: Three locations in Europe and five globally - Acquisition strengthens Adragos' end-to-end integrated pharmaceutical product development service offering - Agreement on further product development activities for Clinigen Munich-based pharmaceutical contract ...
mehrTechnogym is Official Supporter to the Paris 2024 Olympic Games
Paris (ots/PRNewswire) - Technogym is Official and Exclusive Supporter of the cardio, strength and functional training equipment for the athletic preparation of the participants who will compete in the Paris 2024 Olympic and Paralympic Games. In Paris, Technogym will equip 29 training centers for the athletes to train prior to and during the Olympic Games. The main training center, equipped for the need of all sport ...
mehrGermany to Invest Billions, Cut Bureaucracy in Transportation Projects
Berlin (ots) - After marathon negotiations, Germany’s government coalition has agreed to massive investments and streamlined permit procedures for transportation infrastructure. Representatives from the three parties that make up the German government – the center-left Social Democrats, the environmentalist Greens and the business-friendly Free Democrats – have ...
mehrGenialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response
BOSTON, LAUSANNE & LJUBLJANA, Slovenia (ots) - Debiopharm Innovatoin Fund & Taiwania Capital co-lead financing round for Genialis to propel drug development, diagnostics and treatment planning through AI/ML-enabled platform with a biology-first approach Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, ...
mehrDEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCi™ STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM
Lausanne, Switzerland (ots/PRNewswire) - - Debiopharm is developing personalized radiotherapy through a theranostic approach, combining diagnostic imaging (Debio 0328 a gallium-labelled imaging tool) and therapeutic components (Debio 0228, a lutetium-labelled radioligand), thus allowing the pre-identification and ...
mehr